Repetitive transcranial magnetic stimulation (rTMS) is used for treatment of late-life depression. In the FOUR-D study, sequential bilateral theta-burst stimulation (TBS) had comparable remission rates to standard bilateral rTMS. Data were analysed from the FOUR-D trial to compare remission rates between two types of rTMS based on the number and class of prior medication trials. The remission rate was higher in participants with ≤1 previous trial (43.9%) than in participants with 2 previous trials (26.5%) or ≥3 previous trials (24.6%; χ² = 6.36, d.f. = 2, P = 0.04). Utilising rTMS earlier in late-life depression may lead to better outcomes.
CITATION STYLE
Wathra, R. A., Mulsant, B. H., Daskalakis, Z. J., Downar, J., McClintock, S. M., Nestor, S. M., … Blumberger, D. M. (2023). Effect of prior pharmacotherapy on remission with sequential bilateral theta-burst versus standard bilateral repetitive transcranial magnetic stimulation in treatment-resistant late-life depression. British Journal of Psychiatry, 223(5), 504–506. https://doi.org/10.1192/bjp.2023.81
Mendeley helps you to discover research relevant for your work.